| Announce Date | 12/31/1969 |
| EPS Normalized Actual | $ In Line |
| EPS GAAP Actual | $ In Line |
| Revenue Actual | $1.75B |
| Revenue Surprise | Beat by $1750M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $1.427B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2031 | 1.4 | 10.81 | 1.4 | 1.4 | 1 |
| Dec 2030 | -0.22 | -68.79 | -0.22 | -0.22 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.28 | -0.28 | 1.75B | -40.91% | 568M |
| FQ2 2025 (Jun 2025) | -0.32 | -0.32 | 1.802B | -34.46% | 205M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 1.749B | -40.19% | 285M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 1.902B | -30.55% | 529M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 2.466B | 1.34% | 1131M |
| FQ2 2024 (Jun 2024) | -0.51 | -0.51 | 2.423B | 3.96% | 996M |
| FQ1 2024 (Mar 2024) | -0.42 | -0.42 | 2.452B | 8.65% | 1180M |
| FQ4 2023 (Dec 2023) | -0.33 | -0.33 | 2.483B | 100% | 2483M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
1.427B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | -- | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 1.52B | -- | 1.52B | 1.52B | 1 |
| FQ2 2027 (Jun 2027) | 1.46B | -- | 1.46B | 1.46B | 1 |
| FQ1 2027 (Mar 2027) | 1.52B | -- | 1.52B | 1.52B | 1 |
| FQ4 2026 (Dec 2026) | 1.46B | -- | 1.46B | 1.46B | 1 |
| FQ3 2026 (Sep 2026) | 1.37B | -27.46 | 1.37B | 1.37B | 1 |
| FQ2 2026 (Jun 2026) | 1.34B | -34.98 | 1.34B | 1.34B | 1 |
| FQ1 2026 (Mar 2026) | 1.43B | -22.56 | 1.43B | 1.43B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
5
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | -0.28 | -0.28 | 100% |
| FQ2 2025 (Jun 2025) | 0 | -0.32 | -0.32 | 100% |
| FQ1 2025 (Mar 2025) | 0 | 0 | 0 | NAN% |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0 | NAN% |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0 | NAN% |
| FQ2 2024 (Jun 2024) | 0 | -0.51 | -0.51 | 100% |
| FQ1 2024 (Mar 2024) | 0 | -0.42 | -0.42 | 100% |
| FQ4 2023 (Dec 2023) | -0.33 | -0.33 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.18B | $1.75B | $568M | 32.46% |
| FQ2 2025 (Jun 2025) | $1.6B | $1.8B | $205M | 11.38% |
| FQ1 2025 (Mar 2025) | $1.46B | $1.75B | $285M | 16.3% |
| FQ4 2024 (Dec 2024) | $1.37B | $1.9B | $529M | 27.81% |
| FQ3 2024 (Sep 2024) | $1.34B | $2.47B | $1131M | 45.86% |
| FQ2 2024 (Jun 2024) | $1.43B | $2.42B | $996M | 41.11% |
| FQ1 2024 (Mar 2024) | $1.27B | $2.45B | $1180M | 48.12% |
| FQ4 2023 (Dec 2023) | $0B | $2.48B | $2483M | 100% |